Publicacións (12) Publicacións de Eva Costa Arpín

2023

  1. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

2021

  1. Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter

    Neurologia, Vol. 36, Núm. 5, pp. 346-352

  2. SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 5

  3. Temporal trends in the incidence and prevalence of Multiple Sclerosis in the Northwest of Spain

    Multiple Sclerosis and Related Disorders, Vol. 52

2020

  1. Efficacy and safety of fampridine for walking disability in multiple sclerosis

    Neurodegenerative Disease Management, Vol. 10, Núm. 5, pp. 277-287

  2. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain)

    Acta Neurologica Scandinavica, Vol. 142, Núm. 3, pp. 267-274

2019

  1. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test)

    Multiple Sclerosis and Related Disorders, Vol. 28, pp. 50-56

2016

  1. Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab

    Neurodegenerative disease management, Vol. 6, Núm. 1, pp. 5-12

  2. Clinical response and tolerability of fampridine in clinical practice

    Neurodegenerative disease management, Vol. 6, Núm. 2, pp. 99-105

  3. Fingolimod: Efectividad y seguridad en la práctica clínica habitual. Estudio observacional,retrospectivo y multicéntrico en Galicia

    Revista de Neurologia, Vol. 63, pp. S13-S18

2015

  1. Neuropatías, radiculopatías y plexopatías

    Medicine (Spain), Vol. 11, Núm. 78, pp. 4698-4710

2012

  1. Estesioneuroblastoma de presentacion atipica.

    Revista de neurologia